Strong Industry Position c-LEcta's specialization in enzyme engineering and its proprietary platform ENESYZ® position it as a key innovator in the biotechnology sector, offering potential for partnerships with companies seeking advanced biotechnological solutions in food and pharmaceuticals.

Global Customer Base With over 400 customers in more than 40 countries, c-LEcta demonstrates extensive international reach, presenting opportunities to expand distribution channels and develop strategic alliances across diverse markets.

Strategic Acquisition The acquisition by Kerry Group for 155 million dollars signifies strong financial backing and integration into a global leader in taste and nutrition, enabling c-LEcta to leverage Kerry's resources for accelerated growth and new product development.

Collaborative Innovation Partnerships with industry leaders like Symrise and Kerry highlight c-LEcta’s focus on collaborative development, opening avenues for joint ventures targeted at expanding enzyme applications and entering new industrial segments.

Quality Commitment With its early adoption of ISO 9001-certified quality management systems, c-LEcta offers reliable, high-quality biotechnological products, making it an attractive partner for clients prioritizing compliance and consistent standards in regulated markets.